J2407
J2407 – Injection, oritavancin (orbactiv), 10 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 1 NDC crosswalked per 10 MG $29.727/unit ASP+6%
📋 J2407 summary
J2407 is a HCPCS Level II J-code used to bill oritavancin (orbactiv), 10 mg, billed per 10 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2407: Orbactiv
Code J2407
Billing unit 10 MG Payment limit $29.727/unit NDC-Crosswalk 1
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2407
DescriptorInjection, oritavancin (orbactiv), 10 mg
Billing unit10 MG
Payment limit / unit$29.727
Est. ASP / unit$28.044 est.
Mapped NDCs1
Data periodQ3 2026
Last updated2026-08-20
💊 About Oritavancin Injection DRUG GUIDE
Oritavancin injection — available as Orbactiv and Kimyrsa — is used to treat acute bacterial skin and skin structure infections (ABSSSI) in adults.
These are serious skin infections caused by susceptible gram-positive bacteria, including Staphylococcus aureus (including MRSA), several Streptococcus species, and vancomycin-susceptible Enterococcus faecalis.This antibiotic should only be used when a bacterial infection is confirmed or strongly suspected.
Using it unnecessarily can contribute to antibiotic resistance.
Clinical overview from our editorial drug guide for Oritavancin Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$29.727
Est. ASP / unit
$28.044 est.
Est. after 2% sequester
$29.132
HCPCS dosage
10 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, oritavancin (orbactiv), 10 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2021-10-01
Date added2016-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2407 = 10 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2407 WITH EST. MEDICARE PAY
1 NDC map to J2407. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($29.727/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 70842-0140-03 | Orbactiv oritavancin 400 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Melinta | 3 VIAL, GLASS in 1 CARTON (70842-140-03)... | 400 mg/1 | 120 | $3,567.24 | — | ● Active | CMS + PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$354.4K
Claims
108
Beneficiaries
63
Spend / beneficiary
$5,624.63
Spend / claim
$3,281.03
Trend by period
Where J2407 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #473 of 824
#468
CARBOPLATIN* J9045
$364K
#469
EOVIST A9581
$362.8K
#470
OASIS BURN MATRIX** Q4103
$362.6K
#471
METHYLPREDNISOLONE S... J2919
$358.5K
#472
BICILLIN L-A J0561
$356.8K
#473
ORBACTIV J2407
$354.4K
#474
SUBLOCADE(Q9992) Q9992
$345.4K
#475
CYCLOPHOSPHAMIDE(J90... J9074
$344K
#476
IODIXANOL(Q9966)* Q9966
$341.3K
#477
YESINTEK Q5100
$340.6K
#478
ETOPOSIDE J8560
$337.5K
Total claims — #626 of 824
#621
CEFUROXIME SODIUM J0697
109
#622
HYLENEX J3473
109
#623
COCOON MEMBRANE, PER... Q4264
109
#624
BYOOVIZ Q5124
109
#625
ACYCLOVIR SODIUM J0133
108
#626
ORBACTIV J2407
108
#627
EDETATE CALCIUM DISO... J0600
107
#628
GIVLAARI J0223
105
#629
DERMABIND FM, PER SQ... Q4313
102
#630
GAMASTAN J1460
100
#631
MEDROL* J7509
100
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $354.4K | 63 | 108 | $5,624.63 | $3,281.03 |
| 2025 (Q1-Q4) | $2.2M | 313 | 660 | $7,020.68 | $3,329.50 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$792.7K
Medicare paid
$616.5K
Submitted services
30,470
Denial rate
8.9%
Allowed / service
$28.57
Submitted charges
$2.09M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J2407 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 7,320 services across 3 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J2407
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
1 NDC mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2407 billing FAQ
What is HCPCS code J2407?
J2407 is a HCPCS Level II J-code used to bill Injection, oritavancin (orbactiv), 10 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2407?
One unit of J2407 represents 10 MG. Report the number of units equal to the dose administered divided by 10 MG.
How many units of J2407 should I bill?
Divide the dose administered by the code's unit size (10 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2407?
The Medicare Part B payment limit is $29.727 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $29.132 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2407?
1 NDC currently map to J2407 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2407 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.